HEADER HYDROLASE/HYDROLASE INHIBITOR 07-MAY-98 1BDA TITLE CATALYTIC DOMAIN OF HUMAN SINGLE CHAIN TISSUE PLASMINOGEN ACTIVATOR IN TITLE 2 COMPLEX WITH DANSYL-EGR-CMK (DANSYL-GLU-GLY-ARG CHLOROMETHYL KETONE) COMPND MOL_ID: 1; COMPND 2 MOLECULE: SINGLE CHAIN TISSUE TYPE PLASMINOGEN ACTIVATOR; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: UNP RESIDUES 298-562; COMPND 5 SYNONYM: SC-TPA; COMPND 6 EC: 3.4.21.68; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS TRYPSIN LIKE SERINE PROTEASE, FIBRINOLYTIC ENZYMES, PLASMINOGEN KEYWDS 2 ACTIVATORS, HYDROLASE-HYDROLASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.BODE,M.RENATUS,R.A.ENGH REVDAT 5 16-OCT-24 1BDA 1 REMARK REVDAT 4 02-AUG-23 1BDA 1 COMPND REMARK HETNAM LINK REVDAT 3 13-JUL-11 1BDA 1 VERSN REVDAT 2 24-FEB-09 1BDA 1 VERSN REVDAT 1 11-MAY-99 1BDA 0 JRNL AUTH M.RENATUS,R.A.ENGH,M.T.STUBBS,R.HUBER,S.FISCHER,U.KOHNERT, JRNL AUTH 2 W.BODE JRNL TITL LYSINE 156 PROMOTES THE ANOMALOUS PROENZYME ACTIVITY OF TPA: JRNL TITL 2 X-RAY CRYSTAL STRUCTURE OF SINGLE-CHAIN HUMAN TPA. JRNL REF EMBO J. V. 16 4797 1997 JRNL REFN ISSN 0261-4189 JRNL PMID 9305622 JRNL DOI 10.1093/EMBOJ/16.16.4797 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH M.RENATUS,M.T.STUBBS,R.HUBER,P.BRINGMANN,P.DONNER, REMARK 1 AUTH 2 W.D.SCHLEUNING,W.BODE REMARK 1 TITL CATALYTIC DOMAIN STRUCTURE OF VAMPIRE BAT PLASMINOGEN REMARK 1 TITL 2 ACTIVATOR: A MOLECULAR PARADIGM FOR PROTEOLYSIS WITHOUT REMARK 1 TITL 3 ACTIVATION CLEAVAGE REMARK 1 REF BIOCHEMISTRY V. 36 13483 1997 REMARK 1 REFN ISSN 0006-2960 REMARK 1 REFERENCE 2 REMARK 1 AUTH D.LAMBA,M.BAUER,R.HUBER,S.FISCHER,R.RUDOLPH,U.KOHNERT,W.BODE REMARK 1 TITL THE 2.3 A CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF REMARK 1 TITL 2 RECOMBINANT TWO-CHAIN HUMAN TISSUE-TYPE PLASMINOGEN REMARK 1 TITL 3 ACTIVATOR REMARK 1 REF J.MOL.BIOL. V. 258 117 1996 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 3.35 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.851 REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.35 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 7.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 2.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 100000.000 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.2500 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 81.0 REMARK 3 NUMBER OF REFLECTIONS : 6845 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NO FREE R-FACTOR REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : NULL REMARK 3 FREE R VALUE : NULL REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 3.25 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 3.35 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 29.00 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 240 REMARK 3 BIN R VALUE (WORKING SET) : 0.3110 REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4170 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 82 REMARK 3 SOLVENT ATOMS : 19 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.10 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.671 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 25.74 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.386 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 2.090 ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : 3.581 ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : 2.661 ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : 4.228 ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PARHCSDX.PRO REMARK 3 PARAMETER FILE 2 : PARAM19.SOL REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : TOPHCSDX.PRO REMARK 3 TOPOLOGY FILE 2 : NULL REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1BDA COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171616. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-96 REMARK 200 TEMPERATURE (KELVIN) : 290 REMARK 200 PH : 8.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU RUH2R REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM, ROTAGR REMARK 200 DATA SCALING SOFTWARE : ROTAGR REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 9414 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 25.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.7 REMARK 200 DATA REDUNDANCY : 2.900 REMARK 200 R MERGE (I) : 0.14700 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 3.6000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.18 REMARK 200 COMPLETENESS FOR SHELL (%) : 55.2 REMARK 200 DATA REDUNDANCY IN SHELL : 1.70 REMARK 200 R MERGE FOR SHELL (I) : 0.63000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: X-PLOR 3.851 REMARK 200 STARTING MODEL: 1RTF REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.36 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PH 8.2 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 21.99500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 79.58000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 40.39000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 79.58000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 21.99500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 40.39000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 475 REMARK 475 ZERO OCCUPANCY RESIDUES REMARK 475 THE FOLLOWING RESIDUES WERE MODELED WITH ZERO OCCUPANCY. REMARK 475 THE LOCATION AND PROPERTIES OF THESE RESIDUES MAY NOT REMARK 475 BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 475 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE) REMARK 475 M RES C SSEQI REMARK 475 LYS A 36 REMARK 475 HIS A 37 REMARK 475 ARG A 37A REMARK 475 ARG A 37B REMARK 475 SER A 37C REMARK 475 PRO A 37D REMARK 475 ARG A 110D REMARK 475 GLY A 186C REMARK 475 GLY A 186D REMARK 475 PRO A 186E REMARK 475 PRO A 244 REMARK 475 THR B 1A REMARK 475 GLN B 10 REMARK 475 LYS B 36 REMARK 475 HIS B 37 REMARK 475 ARG B 37A REMARK 475 ARG B 37B REMARK 475 SER B 37C REMARK 475 PRO B 37D REMARK 475 ASP B 110A REMARK 475 GLY B 186C REMARK 475 GLY B 186D REMARK 475 PRO B 186E REMARK 475 ARG B 243 REMARK 475 PRO B 244 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLN A 8 CB CG CD OE1 NE2 REMARK 480 GLN A 10 CB CG CD OE1 NE2 REMARK 480 LYS A 92 CG CD CE NZ REMARK 480 LYS A 109 CB CG CD CE NZ REMARK 480 ASP A 110A CB CG OD1 OD2 REMARK 480 SER A 110C C O REMARK 480 GLN A 113 CG CD OE1 NE2 REMARK 480 LEU A 147 CA CB CG CD1 CD2 REMARK 480 GLN A 169B CG CD OE1 NE2 REMARK 480 GLN A 186F CB CG CD OE1 NE2 REMARK 480 LYS A 222 CG CD CE NZ REMARK 480 ARG A 243 CB CG CD NE CZ NH1 NH2 REMARK 480 GLN B 5 CB CG CD OE1 NE2 REMARK 480 ARG B 60B CG CD NE CZ NH1 NH2 REMARK 480 LYS B 92 CG CD CE NZ REMARK 480 LYS B 109 CB CG CD CE NZ REMARK 480 SER B 110C C O REMARK 480 ARG B 110D N CA C O REMARK 480 GLN B 113 CG CD OE1 NE2 REMARK 480 LEU B 147 CB CG CD1 CD2 REMARK 480 GLN B 169B CG CD OE1 NE2 REMARK 480 GLN B 186F CB CG CD OE1 NE2 REMARK 480 ASP B 204 CG OD1 OD2 REMARK 480 LYS B 222 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 199 N - CA - C ANGL. DEV. = -17.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE A 11 88.86 163.26 REMARK 500 LEU A 20 137.22 177.89 REMARK 500 PRO A 28 -1.18 -55.69 REMARK 500 HIS A 37 -165.89 -102.63 REMARK 500 HIS A 62 29.44 -72.00 REMARK 500 LYS A 92 -9.53 -55.96 REMARK 500 PHE A 94 101.07 -57.53 REMARK 500 ASP A 102 96.01 -68.62 REMARK 500 ILE A 103 144.57 -171.20 REMARK 500 CYS A 111 -80.03 -125.70 REMARK 500 GLN A 129 83.05 -154.33 REMARK 500 PRO A 131 176.80 -57.34 REMARK 500 TRP A 133 28.32 38.41 REMARK 500 GLU A 145 146.84 174.32 REMARK 500 ALA A 146 -76.05 -29.30 REMARK 500 LEU A 171 68.23 -113.09 REMARK 500 LEU A 172 39.21 37.86 REMARK 500 ASN A 173 -14.45 70.54 REMARK 500 SER A 186B -150.10 176.37 REMARK 500 PRO A 186E 76.82 -37.98 REMARK 500 GLN A 186F 129.89 66.08 REMARK 500 ASN A 203 116.31 -163.51 REMARK 500 LEU A 217 91.30 -64.92 REMARK 500 CYS A 220 89.36 -154.90 REMARK 500 LYS A 230 90.21 -68.19 REMARK 500 PRO B 9 95.71 -66.37 REMARK 500 GLN B 10 46.70 -83.73 REMARK 500 PHE B 11 118.18 -166.13 REMARK 500 LEU B 20 135.69 -173.79 REMARK 500 PRO B 28 0.44 -57.82 REMARK 500 ARG B 37A 104.92 -56.68 REMARK 500 SER B 49 -1.16 -47.05 REMARK 500 CYS B 50 16.61 -162.98 REMARK 500 GLU B 60A -17.47 -46.79 REMARK 500 PRO B 61 -41.63 -27.55 REMARK 500 LYS B 92 -8.10 -50.15 REMARK 500 PHE B 94 108.09 -48.92 REMARK 500 THR B 98 1.74 -160.93 REMARK 500 ASN B 101 35.52 80.20 REMARK 500 CYS B 111 -73.30 -82.26 REMARK 500 ALA B 126 -38.83 -33.62 REMARK 500 ASP B 127 35.07 -86.17 REMARK 500 PRO B 131 173.94 -56.10 REMARK 500 TRP B 133 24.18 41.48 REMARK 500 TYR B 141 34.80 -140.08 REMARK 500 ARG B 174 -154.83 -70.53 REMARK 500 ASP B 178 36.97 -76.71 REMARK 500 ARG B 186A 172.42 -57.03 REMARK 500 SER B 186B -152.76 173.06 REMARK 500 PRO B 186E 79.21 -40.06 REMARK 500 REMARK 500 THIS ENTRY HAS 55 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 THE UNBOUND FORM OF THE INHIBITOR IS DANSYL-GLU-GLY-ARG-CMK- REMARK 600 CHLOROMETHYLKETONE. UPON REACTION WITH PROTEIN IT FORMS TWO REMARK 600 COVALENT BONDS: 1) A COVALENT BOND TO SER 195 FORMING A HEMIKETAL REMARK 600 AR7 AND 2) A COVALENT BOND TO NE2 OF HIS 57 REMARK 630 REMARK 630 MOLECULE TYPE: PEPTIDE-LIKE INHIBITOR REMARK 630 MOLECULE NAME: N-{[5-(DIMETHYLAMINO)NAPHTHALEN-2-YL]SULFONYL}-L- REMARK 630 ALPHA-GLUTAMYL-N-[(1S)-4-{[AMINO(IMINIO)METHYL]AMINO}-1- REMARK 630 (CHLOROACETYL) BUTYL]GLYCINAMIDE REMARK 630 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 630 SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 630 REMARK 630 M RES C SSSEQI REMARK 630 2Z0 A 245 REMARK 630 2Z0 B 245 REMARK 630 SOURCE: NULL REMARK 630 TAXONOMY: NULL REMARK 630 SUBCOMP: DSY GLU GLY AR7 0QE REMARK 630 DETAILS: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2Z0 A 245 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 2Z0 B 245 DBREF 1BDA A 1 244 UNP P00750 TPA_HUMAN 298 562 DBREF 1BDA B 1 244 UNP P00750 TPA_HUMAN 298 562 SEQRES 1 A 265 THR CYS GLY LEU ARG GLN TYR SER GLN PRO GLN PHE ARG SEQRES 2 A 265 ILE LYS GLY GLY LEU PHE ALA ASP ILE ALA SER HIS PRO SEQRES 3 A 265 TRP GLN ALA ALA ILE PHE ALA LYS HIS ARG ARG SER PRO SEQRES 4 A 265 GLY GLU ARG PHE LEU CYS GLY GLY ILE LEU ILE SER SER SEQRES 5 A 265 CYS TRP ILE LEU SER ALA ALA HIS CYS PHE GLN GLU ARG SEQRES 6 A 265 PHE PRO PRO HIS HIS LEU THR VAL ILE LEU GLY ARG THR SEQRES 7 A 265 TYR ARG VAL VAL PRO GLY GLU GLU GLU GLN LYS PHE GLU SEQRES 8 A 265 VAL GLU LYS TYR ILE VAL HIS LYS GLU PHE ASP ASP ASP SEQRES 9 A 265 THR TYR ASP ASN ASP ILE ALA LEU LEU GLN LEU LYS SER SEQRES 10 A 265 ASP SER SER ARG CYS ALA GLN GLU SER SER VAL VAL ARG SEQRES 11 A 265 THR VAL CYS LEU PRO PRO ALA ASP LEU GLN LEU PRO ASP SEQRES 12 A 265 TRP THR GLU CYS GLU LEU SER GLY TYR GLY LYS HIS GLU SEQRES 13 A 265 ALA LEU SER PRO PHE TYR SER GLU ARG LEU LYS GLU ALA SEQRES 14 A 265 HIS VAL ARG LEU TYR PRO SER SER ARG CYS THR SER GLN SEQRES 15 A 265 HIS LEU LEU ASN ARG THR VAL THR ASP ASN MET LEU CYS SEQRES 16 A 265 ALA GLY ASP THR ARG SER GLY GLY PRO GLN ALA ASN LEU SEQRES 17 A 265 HIS ASP ALA CYS GLN GLY ASP SER GLY GLY PRO LEU VAL SEQRES 18 A 265 CYS LEU ASN ASP GLY ARG MET THR LEU VAL GLY ILE ILE SEQRES 19 A 265 SER TRP GLY LEU GLY CYS GLY GLN LYS ASP VAL PRO GLY SEQRES 20 A 265 VAL TYR THR LYS VAL THR ASN TYR LEU ASP TRP ILE ARG SEQRES 21 A 265 ASP ASN MET ARG PRO SEQRES 1 B 265 THR CYS GLY LEU ARG GLN TYR SER GLN PRO GLN PHE ARG SEQRES 2 B 265 ILE LYS GLY GLY LEU PHE ALA ASP ILE ALA SER HIS PRO SEQRES 3 B 265 TRP GLN ALA ALA ILE PHE ALA LYS HIS ARG ARG SER PRO SEQRES 4 B 265 GLY GLU ARG PHE LEU CYS GLY GLY ILE LEU ILE SER SER SEQRES 5 B 265 CYS TRP ILE LEU SER ALA ALA HIS CYS PHE GLN GLU ARG SEQRES 6 B 265 PHE PRO PRO HIS HIS LEU THR VAL ILE LEU GLY ARG THR SEQRES 7 B 265 TYR ARG VAL VAL PRO GLY GLU GLU GLU GLN LYS PHE GLU SEQRES 8 B 265 VAL GLU LYS TYR ILE VAL HIS LYS GLU PHE ASP ASP ASP SEQRES 9 B 265 THR TYR ASP ASN ASP ILE ALA LEU LEU GLN LEU LYS SER SEQRES 10 B 265 ASP SER SER ARG CYS ALA GLN GLU SER SER VAL VAL ARG SEQRES 11 B 265 THR VAL CYS LEU PRO PRO ALA ASP LEU GLN LEU PRO ASP SEQRES 12 B 265 TRP THR GLU CYS GLU LEU SER GLY TYR GLY LYS HIS GLU SEQRES 13 B 265 ALA LEU SER PRO PHE TYR SER GLU ARG LEU LYS GLU ALA SEQRES 14 B 265 HIS VAL ARG LEU TYR PRO SER SER ARG CYS THR SER GLN SEQRES 15 B 265 HIS LEU LEU ASN ARG THR VAL THR ASP ASN MET LEU CYS SEQRES 16 B 265 ALA GLY ASP THR ARG SER GLY GLY PRO GLN ALA ASN LEU SEQRES 17 B 265 HIS ASP ALA CYS GLN GLY ASP SER GLY GLY PRO LEU VAL SEQRES 18 B 265 CYS LEU ASN ASP GLY ARG MET THR LEU VAL GLY ILE ILE SEQRES 19 B 265 SER TRP GLY LEU GLY CYS GLY GLN LYS ASP VAL PRO GLY SEQRES 20 B 265 VAL TYR THR LYS VAL THR ASN TYR LEU ASP TRP ILE ARG SEQRES 21 B 265 ASP ASN MET ARG PRO HET 2Z0 A 245 41 HET 2Z0 B 245 41 HETNAM 2Z0 N-{[5-(DIMETHYLAMINO)NAPHTHALEN-2-YL]SULFONYL}-L-ALPHA- HETNAM 2 2Z0 GLUTAMYL-N-[(1S)-4-{[AMINO(IMINIO)METHYL]AMINO}-1- HETNAM 3 2Z0 (CHLOROACETYL) BUTYL]GLYCINAMIDE HETSYN 2Z0 DANSYL-GLU-GLY-ARG-CHLOROMETHYL-KETONE FORMUL 3 2Z0 2(C26 H37 CL N7 O7 S 1+) FORMUL 5 HOH *19(H2 O) HELIX 1 1 ILE A 24 HIS A 27 5 4 HELIX 2 2 HIS A 57 PHE A 59 5 3 HELIX 3 3 PRO A 61 HIS A 63 5 3 HELIX 4 4 SER A 165 ARG A 167 5 3 HELIX 5 5 VAL A 231 ASP A 240 5 10 HELIX 6 6 ILE B 24 HIS B 27 5 4 HELIX 7 7 ALA B 56 PHE B 59 5 4 HELIX 8 8 PRO B 61 HIS B 63 5 3 HELIX 9 9 SER B 165 ARG B 167 5 3 HELIX 10 10 VAL B 231 ASP B 240 1 10 SHEET 1 A 7 ALA A 31 ALA A 35 0 SHEET 2 A 7 LEU A 64 LEU A 68 -1 N ILE A 67 O ALA A 32 SHEET 3 A 7 GLN A 81 VAL A 90 -1 N PHE A 83 O VAL A 66 SHEET 4 A 7 ALA A 104 LYS A 109 -1 N LYS A 109 O GLU A 84 SHEET 5 A 7 TRP A 51 SER A 54 -1 N SER A 54 O ALA A 104 SHEET 6 A 7 GLU A 38 SER A 48 -1 N SER A 48 O TRP A 51 SHEET 7 A 7 GLN A 30 LYS A 36 -1 N ALA A 35 O ARG A 39 SHEET 1 B 6 LYS A 156 ARG A 161 0 SHEET 2 B 6 GLU A 135 GLY A 140 -1 N GLY A 140 O LYS A 156 SHEET 3 B 6 PRO A 198 ASN A 203 -1 N VAL A 200 O GLU A 137 SHEET 4 B 6 ARG A 206 TRP A 215 -1 N GLY A 211 O LEU A 199 SHEET 5 B 6 GLY A 226 LYS A 230 -1 N THR A 229 O ILE A 212 SHEET 6 B 6 MET A 180 ALA A 183 -1 N ALA A 183 O GLY A 226 SHEET 1 C 7 ALA B 31 ALA B 35 0 SHEET 2 C 7 LEU B 64 LEU B 68 -1 N ILE B 67 O ALA B 32 SHEET 3 C 7 GLN B 81 VAL B 90 -1 N PHE B 83 O VAL B 66 SHEET 4 C 7 ILE B 103 LYS B 109 -1 N LYS B 109 O GLU B 84 SHEET 5 C 7 TRP B 51 ALA B 55 -1 N SER B 54 O ALA B 104 SHEET 6 C 7 PHE B 40 SER B 48 -1 N SER B 48 O TRP B 51 SHEET 7 C 7 GLN B 30 PHE B 34 -1 N ILE B 33 O LEU B 41 SHEET 1 D 2 GLU B 135 GLY B 140 0 SHEET 2 D 2 LYS B 156 ARG B 161 -1 N VAL B 160 O CYS B 136 SHEET 1 E 4 MET B 180 ALA B 183 0 SHEET 2 E 4 GLY B 226 LYS B 230 -1 N TYR B 228 O LEU B 181 SHEET 3 E 4 ARG B 206 TRP B 215 -1 N TRP B 215 O VAL B 227 SHEET 4 E 4 PRO B 198 ASN B 203 -1 N ASN B 203 O ARG B 206 SSBOND 1 CYS A 1 CYS A 122 1555 1555 2.02 SSBOND 2 CYS A 42 CYS A 58 1555 1555 2.01 SSBOND 3 CYS A 50 CYS A 111 1555 1555 2.03 SSBOND 4 CYS A 136 CYS A 201 1555 1555 2.03 SSBOND 5 CYS A 168 CYS A 182 1555 1555 2.02 SSBOND 6 CYS A 191 CYS A 220 1555 1555 2.03 SSBOND 7 CYS B 1 CYS B 122 1555 1555 2.02 SSBOND 8 CYS B 42 CYS B 58 1555 1555 2.03 SSBOND 9 CYS B 50 CYS B 111 1555 1555 2.03 SSBOND 10 CYS B 136 CYS B 201 1555 1555 2.03 SSBOND 11 CYS B 168 CYS B 182 1555 1555 2.02 SSBOND 12 CYS B 191 CYS B 220 1555 1555 2.01 LINK NE2 HIS A 57 CE 2Z0 A 245 1555 1555 1.52 LINK OG SER A 195 CC 2Z0 A 245 1555 1555 1.40 LINK NE2 HIS B 57 CE 2Z0 B 245 1555 1555 1.53 LINK OG SER B 195 CC 2Z0 B 245 1555 1555 1.42 SITE 1 AC1 15 HIS A 57 TYR A 99 ARG A 174 ASP A 189 SITE 2 AC1 15 ALA A 190 GLY A 193 SER A 195 SER A 214 SITE 3 AC1 15 TRP A 215 GLY A 216 GLY A 219 TRP B 133 SITE 4 AC1 15 TYR B 163 ARG B 167 ASP B 223 SITE 1 AC2 18 TRP A 133 TYR A 163 ARG A 167 ASP A 185 SITE 2 AC2 18 ASP A 223 HIS B 57 TYR B 99 ARG B 174 SITE 3 AC2 18 ASP B 189 ALA B 190 GLN B 192 GLY B 193 SITE 4 AC2 18 SER B 195 SER B 214 TRP B 215 GLY B 216 SITE 5 AC2 18 LEU B 217 GLY B 219 CRYST1 43.990 80.780 159.160 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022732 0.000000 0.000000 0.00000 SCALE2 0.000000 0.012379 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006283 0.00000 MTRIX1 1 -0.999957 -0.001563 -0.009178 22.41300 1 MTRIX2 1 0.001411 -0.999863 0.016518 64.09110 1 MTRIX3 1 -0.009203 0.016504 0.999821 -0.25990 1 MTRIX1 2 -0.998807 -0.037285 -0.031526 25.05300 1 MTRIX2 2 0.036553 -0.999055 0.023500 63.25160 1 MTRIX3 2 -0.032372 0.022320 0.999227 -0.29250 1